Related Experiment Video
Updated: May 2, 2026
23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.7K
AIDS-related mycoses: the way forward
Gordon D Brown1, Graeme Meintjes2, Jay K Kolls3
1Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, 7925, Cape Town, South Africa; Aberdeen Fungal Group, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, AB25 2ZD, UK.
Trends in Microbiology
|March 4, 2014
Summary
Fungal infections significantly impact HIV patients, yet this threat is often overlooked. Addressing this requires better surveillance, diagnostics, drugs, training, and research funding, especially in developing nations.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health
Background:
- Fungal infections are a significant, underrecognized cause of illness and death in individuals with human immunodeficiency virus (HIV).
- A recent expert meeting identified critical gaps in addressing fungal coinfections in HIV.
- The burden of fungal diseases in immunocompromised populations remains poorly quantified.
Framework:
- The meeting established key priorities for advancing the management of fungal infections in HIV.
- Focus areas include enhancing diagnostic capabilities and therapeutic accessibility.
- Strengthening medical mycology education and research infrastructure is crucial.
Implementation:
- Urgent need for improved epidemiological surveillance of fungal infections in HIV-positive individuals.
- Increased availability and accessibility of current antifungal diagnostics and medications.
- Enhanced training programs for healthcare professionals in medical mycology.
Implications:
- Improved patient outcomes and reduced mortality in HIV-infected populations through targeted interventions.
- Strengthened healthcare systems, particularly in developing countries, to manage opportunistic fungal infections.
- Advancing research funding for novel diagnostics, treatments, and a deeper understanding of fungal pathogenesis in HIV.
More Related Videos
Related Concept Videos
01:15Antifungal Agents
119
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
119
01:10Retrovirus Life Cycles
43.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
43.0K
01:28Fungal Phylum Microsporidia
782
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
782
01:23Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
01:24Cystic Fibrosis: Management
657
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
657
01:26Sexually Transmitted Infections
2.0K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
2.0K